Iranian trial on functional abdominal pain in children, with the use of L. reuteri DSM 17938. There were no differences between L. reuteri and placebo groups for frequency and severity of abdominal pain. Study population seems biased compared to previously published studies on effects of L. reuteri DSM 17938. 

Link to study article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662837/

 

Reference

Eftekhari K, Vahedi Z, Kamali Aghdam M, Noemi Diaz D. A randomized double-blind placebo-controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children. Iran J Pediatr. 2015;25(6):e2616.

Crawling baby

For the avoidance of doubt, BioGaia’s products are food supplements, and the information on this part of the website should not be interpreted as our products are intended to diagnose, treat, cure or prevent any disease.

The information on this part of the website is intended only for health care and business professionals. If you are not a health care or business professional and would like to learn more about the indications BioGaia works with, please visit our Expertise pages.

Please read terms & conditions before accepting. By clicking on the button “I acknowledge and accept” you confirm that you are a healthcare or business professional and have read and understood this disclaimer including the terms and conditions.